Cedars Sinai tool predicts the best chemotherapy regimen for advanced pancreatic cancer using AI analysis of biopsy images.
FDA approval of a Guardant Health blood test that screens for colorectal cancer makes it the first liquid biopsy approved for this type of cancer, clearing the way to make this test more accessible to ...
A liquid biopsy identifies cellular biomarkers, such as circulating tumor DNA, RNA, microRNA, platelets and endothelial cells. These provide a more nuanced profile of the cancer than a tissue biopsy.
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology. However, technological ...
Many people feel scared when a doctor suggests a biopsy. One very common fear is this: "If I do a biopsy, will the cancer spread?" Because of this fear, many people delay tests or avoid doctors ...
In the field of medical science, non-invasive monitoring is often considered the most promising — and challenging — avenue for healthcare. For example, Apple is exploring non-invasive blood glucose ...
University of Chicago researchers have developed a liquid biopsy test based on modification patterns in microbiome-derived cell-free RNA that predicts colorectal cancer (CRC) with greater accuracy ...
A research team affiliated with UNIST has unveiled an innovative, cost-effective biosensor capable of being washed and reused, paving the way for more accessible liquid biopsy diagnostics. This new ...
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Dear Doctors: My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs a liquid biopsy. She has already had a biopsy — that’s how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results